Genome-wide sequencing for prenatal detection of fetal single-gene disorders

Cold Spring Harbor Perspectives in Medicine

Volumn 5, Issue 10, 2015, Pages

  Van den Veyver, Ignatia B ^b   Eng, Christine M ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; DNA DETERMINATION; EXOME; FETUS; FETUS DISEASE; GENE SEQUENCE; GENOME ANALYSIS; HUMAN; NEXT GENERATION SEQUENCING; PRENATAL CARE; PRENATAL DIAGNOSIS; AMNION FLUID; CHEMISTRY; CHORION VILLUS SAMPLING; CONFIDENTIALITY; DNA SEQUENCE; ECONOMICS; ETHICS; FEMALE; FETAL DISEASES; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN GENOME; INCIDENTAL FINDING; INFORMED CONSENT; MUTATION; PATIENT SATISFACTION; PHENOTYPE; PREGNANCY; PROCEDURES;

AMNIOTIC FLUID; CHORIONIC VILLI SAMPLING; CONFIDENTIALITY; EXOME; FEMALE; FETAL DISEASES; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC TESTING; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INCIDENTAL FINDINGS; INFORMED CONSENT; MUTATION; PATIENT SATISFACTION; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84943279493     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a023077     Document Type: Article

References (95)

1. ACOG. 2013. Committee OpinionNo. 581: The use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 122: 1374-1377.
2. Alamillo CM, Fiddler M, Pergament E. 2012. Increased nuchal translucency in the presence of normal chromosomes: What's next? Curr Opin Obstet Gynecol 24: 102- 108.
3. Anderson JA,Hayeems RZ, Shuman C, Szego MJ,Monfared N, Bowdin S, Zlotnik Shaul R,Meyn MS. 2014. Predictive genetic testing for adult-onset disorders in minors: A critical analysis of the arguments for and against the 2013 ACMG guidelines. Clin Genet 10.1111/cge.12460.
4. Appelbaum PS,Waldman CR, Fyer A, Klitzman R, Parens E, Martinez J, Price WN II, Chung WK. 2014. Informed consent for return of incidental findings in genomic research. Genet Med 16: 367-373.
5. Atwal PS, Brennan ML, Cox R, Niaki M, Platt J, HomeyerM, Kwan A, Parkin S, Schelley S, Slattery L, et al. 2014. Clinical whole-exome sequencing: Are we there yet? Genet Med 16: 717-719.
6. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. 2011. Exome sequencing as a tool forMendelian disease gene discovery. Nat Rev Genet 12: 745-755.
7. Beaulieu CL, Majewski J, Schwartzentruber J, Samuels ME, Fernandez BA, Bernier FP, Brudno M, Knoppers B,Marcadier J, Dyment D, et al. 2014. FORGE Canada Consortium: Outcomes of a 2-year national rare-disease genediscovery project. Am J Hum Genet 94: 809-817.
8. Berg JS, Khoury MJ, Evans JP. 2011. Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genet Med 13: 499-504.
9. Berg JS, Adams M, Nassar N, Bizon C, Lee K, Schmitt CP, Wilhelmsen KC, Evans JP. 2013a. An informatics approach to analyzing the incidentalome. Genet Med 15: 36-44.
10. Berg JS, Amendola LM, Eng C, Van Allen E, Gray SW,Wagle N, Rehm HL, DeChene ET, Dulik MC, Hisama FM, et al. 2013b. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Genet Med 15: 860-867.
11. Bianchi DW, Wilkins-Haug L. 2014. Integration of noninvasive DNA testing for aneuploidy into prenatal care: What has happened since the rubber met the road? Clin Chem 60: 78-87.
12. Bick D, Dimmock D. 2011. Whole exome and whole genome sequencing. Curr Opin Pediatr 23: 594-600.
13. Biesecker LG, Green RC. 2014. Diagnostic clinical genome and exome sequencing. N Engl J Med 371: 1170.
14. Borgelt E, Anderson JA, Illes J. 2013. Managing incidental findings: Lessons from neuroimaging. Am J Bioeth 13: 46-47.
15. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K. 2006. Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clin Genet 70: 374-381.
16. Brett M,McPherson J, Zang ZJ, Lai A, Tan ES, Ng I, Ong LC, Cham B, Tan P, Rozen S, et al. 2014. Massively parallel sequencing of patients with intellectual disability, congenital anomalies and/or autism spectrum disorders with a targeted gene panel. PLoS ONE 9: e93409.
17. Bui TH, Raymond FL, Van den Veyver IB. 2014. Current controversies in prenatal diagnosis 2: Should incidental findings arising from prenatal testing always be reported to patients? Prenat Diagn 34: 12-17.
18. Carss KJ, Hillman SC, Parthiban V, McMullan DJ, Maher ER, Kilby MD, Hurles ME. 2014. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet 23: 3269-3277.
19. Cassa CA, Tong MY, Jordan DM. 2013. Large numbers of genetic variants considered to be pathogenic are common in asymptomatic individuals. Hum Mutat 34: 1216-1220.
20. Chen PC, Yin J, Yu HW, Yuan T, Fernandez M, Yung CK, Trinh QM, Peltekova VD, Reid JG, Tworog-Dube E, et al. 2014.Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci 111: 11473-11478.
21. Christenhusz GM, Devriendt K, Dierickx K. 2013. Secondary variants-In defense of a more fitting term in the incidental findings debate. Eur J Hum Genet 21: 1331- 1334.
22. de Ligt J,Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto-van Silfhout AT, Koolen DA, de Vries P, et al. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367: 1921-1929.
23. Ding LE, Burnett L, Chesher D. 2014. The impact of reporting incidental findings from exome and whole-genome sequencing: Predicted frequencies based on modeling. Genet Med doi: 10.1038/gim.2014.94.
24. Dorschner MO, Amendola LM, Turner EH, Robertson PD, Shirts BH, Gallego CJ, Bennett RL, Jones KL, Tokita MJ, Bennett JT, et al. 2013. Actionable, pathogenic incidental findings in 1,000 participants' exomes. Am J Hum Genet 93: 631-640.
25. Dyment DA, Tetreault M, Beaulieu CL, Hartley T, Ferreira P, Chardon JW, Marcadier J, Sawyer SL, Mosca SJ, Innes AM, et al. 2014. Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: A retrospective study. Clin Genet doi: 10.1111/cge.12464.
26. Eng CM, Yang Y, Plon SE. 2014. Genetic diagnosis through whole-exome sequencing. N Engl J Med 370: 1068.
27. ESHG. 2009. Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. Eur J Hum Genet 17: 720-721.
28. Fahiminiya S, Almuriekhi M, Nawaz Z, Staffa A, Lepage P, Ali R, Hashim L, Schwartzentruber J, Abu Khadija K, Zaineddin S, et al. 2014. Whole exome sequencing unravels disease-causing genes in consanguineous families in Qatar. Clin Genet 86: 134-141.
29. Fan HC, GuW,Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. 2012. Non-invasive prenatal measurement of the fetal genome. Nature 487: 320-324.
30. Fernandez CV, Bouffet E,Malkin D, Jabado N, O'Connell C, Avard D, Knoppers BM, Ferguson M, Boycott KM, Sorensen PH, et al. 2014. Attitudes of parents toward the return of targeted and incidental genomic research findings in children. Genet Med 16: 633-640.
31. Filges I, Friedman JM. 2014. Exome sequencing for gene discovery in lethal fetal disorders-Harnessing the value of extreme phenotypes. Prenat Diagn doi: 10.1002/ pd.4464.
32. Filges I,Nosova E, Bruder E, Tercanli S, Townsend K, Gibson WT, Rothlisberger B, Heinimann K, Hall JG, Gregory-Evans CY, et al. 2014. Exome sequencing identifies mutations in KIF14 as a novel cause of an autosomal recessive lethal fetal ciliopathy phenotype. Clin Genet 86: 220-228.
33. Fujikura K, Setsu T, Tanigaki K, Abe T, Kiyonari H, Terashima T, Sakisaka T. 2013. Kif14 mutation causes severe brain malformation and hypomyelination. PLoS ONE 8: e53490.
34. Geifman-Holtzman O, Grotegut CA, Gaughan JP. 2006. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-A meta-analysis. Am J Obstet Gynecol 195: 1163-1173.
35. Gilissen C, Hoischen A, Brunner HG, Veltman JA. 2011. Unlocking Mendelian disease using exome sequencing. Genome Biol 12: 228.
36. Gilissen C, Hoischen A, Brunner HG, Veltman JA. 2012. Disease gene identification strategies for exome sequencing. Eur J Hum Genet 20: 490-497.
37. Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW,WillemsenMH,Kwint M, Janssen IM, Hoischen A, Schenck AL, et al. 2014. Genome sequencing identifies major causes of severe intellectual disability. Nature 511: 344-347.
38. Gonzaga-Jauregui C, Lupski JR, Gibbs RA. 2012. Human genome sequencing in health and disease. Annu Rev Med 63: 35-61.
39. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, et al. 2013a. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 15: 565-574.
40. Green RC, Lupski JR, Biesecker LG. 2013b. Reporting genomic sequencing results to ordering clinicians: Incidental, but not exceptional. JAMA 310: 365-366.
41. Hennekam RC, Biesecker LG. 2012. Next-generation sequencing demands next-generation phenotyping. Hum Mutat 33: 884-886.
42. Hillman SC, McMullan DJ, Hall G, Togneri FS, James N, Maher EJ,Meller CH,WilliamsD,Wapner RJ,Maher ER, et al. 2013. Use of prenatal chromosomal microarray: Prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 41: 610-620.
43. Hillman SC,WillamsD, Carss KJ,McMullan DJ,Hurles ME, Kilby MD. 2014. Review: Prenatal genetic diagnosis for fetuses with structural abnormalities, the next step. Ultrasound Obstet Gynecol doi: 10.1002/uog.14653.
44. Holm IA, Savage SK, Green RC, Juengst E, McGuire A, Kornetsky S, Brewster SJ, Joffe S, Taylor P. 2014. Guidelines for return of research results frompediatric genomic studies: Deliberations of the Boston Children's Hospital Gene Partnership InformedCohort Oversight Board. Genet Med 16: 547-552.
45. Hui L, Bianchi DW. 2013. Recent advances in the prenatal interrogation of the human fetal genome. Trends Genet 29: 84-91.
46. Iglesias A, Anyane-Yeboa K, Wynn J, Wilson A, Truitt Cho M, Guzman E, Sisson R, Egan C, Chung WK. 2014. The usefulness of whole-exome sequencing in routine clinical practice. Genet Med 16: 922-931.
47. Jones MA, Rhodenizer D, da Silva C, Huff IJ, Keong L, Bean LJ, Coffee B, Collins C, Tanner AK, He M, et al. 2013. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): Detection rate for single gene testing and next generation sequencing panel testing. Mol Genet Metab 110: 78-85.
48. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE, Gammill HS, Rubens CE, Santillan DA, Murray JC, et al. 2012. Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 4: 137ra176.
49. Korf BR. 2013. Integration of genomics into medical practice. Discov Med 16: 241-248.
50. Korf BR, Rehm HL. 2013. New approaches to molecular diagnosis. JAMA 309: 1511-1521.
51. Krier JB, Green RC. 2013. Management of incidental findings in clinical genomic sequencing. Curr Protoc Hum Genet doi: 10.1002/0471142905.hg0923s77.
52. Lau TK, Jiang FM, Stevenson RJ, Lo TK, Chan LW, Chan MK, Lo PS, Wang W, Zhang HY, Chen F, et al. 2013. Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service. Prenat Diagn 33: 602-608.
53. Lau TK, Cheung SW, Lo PS, Pursley AN, Chan MK, Jiang F, Zhang H, Wang W, Jong LF, Yuen OK, et al. 2014. Noninvasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: Review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol 43: 254- 264.
54. Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero- Rivera F, Das K, Toy T, Harry B, Yourshaw M, et al. 2014. Clinical exome sequencing for genetic identification of rareMendelian disorders. JAMA 312: 1880-1887.
55. Lemke JR, Riesch E, Scheurenbrand T, Schubach M, Wilhelm C, Steiner I, Hansen J, Courage C, Gallati S, Burki S, et al. 2012. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 53: 1387-1398.
56. Lench N, Barrett A, Fielding S, McKay F, Hill M, Jenkins L, White H, Chitty LS. 2013. The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: Challenges and progress made. Prenat Diagn 33: 555-562.
57. Lepri FR, Scavelli R, Digilio MC, Gnazzo M, Grotta S, Dentici ML, Pisaneschi E, Sirleto P, Capolino R, Baban A, et al. 2014. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing. BMC Med Genet 15: 14.
58. Lewis C, Hill M, Chitty LS. 2014. Non-invasive prenatal diagnosis for single gene disorders: Experience of patients. Clin Genet 85: 336-342.
59. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. 1997. Presence of fetal DNA in maternal plasma and serum. Lancet 350: 485- 487.
60. Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS. 1998. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma [see comments]. N Engl J Med 339: 1734-1738.
61. Lo YM, Chan KC, Sun H, Chen EZ, Jiang P, Lun FM, Zheng YW, Leung TY, Lau TK, Cantor CR, et al. 2010. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2: 61ra91.
62. Lohn Z, Adam S, Birch PH, Friedman JM. 2013. Incidental findings from clinical genome-wide sequencing: A review. J Genet Couns 23: 436-473.
63. MacArthur DG, Balasubramanian S, Frankish A, Huang N, Morris J, Walter K, Jostins L, Habegger L, Pickrell JK, Montgomery SB, et al. 2012. A systematic survey of loss-of-function variants in human protein-coding genes. Science 335: 823-828.
64. Makrythanasis P,Nelis M, Santoni FA, Guipponi M,Vannier A, Bena F, Gimelli S, Stathaki E, Temtamy S, Megarbane A, et al. 2014. Diagnostic exome sequencing to elucidate the genetic basis of likely recessive disorders in consanguineous families. Hum Mutat 35: 1203-1210.
65. Mand C, Gillam L, Delatycki MB, Duncan RE. 2012. Predictive genetic testing in minors for late-onset conditions: A chronological and analytical review of the ethical arguments. J Med Ethics 38: 519-524.
66. Manolio TA, Murray MF. 2014. The growing role of professional societies in educating clinicians in genomics. Genet Med 16: 571-572.
67. McGuire AL, Lupski JR. 2010. Personal genome research: What should the participant be told? Trends Genet 26: 199-201.
68. McGuire AL, Joffe S, Koenig BA, Biesecker BB,McCullough LB, Blumenthal-Barby JS, Caulfield T, Terry SF, Green RC. 2013a. Point-counterpoint. Ethics and genomic incidental findings. Science 340: 1047-1048.
69. McGuire AL, McCullough LB, Evans JP. 2013b. The indispensable role of professional judgment in genomic medicine. JAMA 309: 1465-1466.
70. McGuire AL, Robinson JO, Ramoni RB, Morley DS, Jofe S, Plon SE. 2013c. Returning genetic research results: Study type matters. Per Med 10: 27-34.
71. Onoufriadis A, Shoemark A, Schmidts M, Patel M, Jimenez G, Liu H, Thomas B, Dixon M, Hirst RA, Rutman A, et al. 2014. Targeted NGS gene panel identifies mutations in RSPH1 causing primary ciliary dyskinesia and a common mechanism for ciliary central pair agenesis due to radial spoke defects. Hum Mol Genet 23: 3362-3374.
72. Piton A, Redin C, Mandel JL. 2013. XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing. Am J Hum Genet 93: 368-383.
73. Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E. 2013. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15: 733-747.
74. Reid JG, Carroll A, Veeraraghavan N, Dahdouli M, Sundquist A, English A, Bainbridge M, White S, Salerno W, Buhay C, et al. 2014. Launching genomics into the cloud: Deployment of Mercury, a next generation sequence analysis pipeline. BMC Bioinformatics 15: 30.
75. Rios JJ, Delgado MR. 2014. Using whole-exome sequencing to identify variants inherited from mosaic parents. Eur J Hum Genet doi: 10.1038/ejhg.2014.125.
76. Ross LF, Rothstein MA, Clayton EW. 2013. Mandatory extended searches in all genome sequencing: "Incidental findings," patient autonomy, and shared decision making. JAMA 310: 367-368.
77. Schaaf CP, Wiszniewska J, Beaudet AL. 2011. Copy number and SNP arrays in clinical diagnostics. Annu Rev Genomics Hum Genet 12: 25-51.
78. Scollon S, Bergstrom K, Kerstein RA, Wang T, Hilsenbeck SG, Ramamurthy U, Gibbs RA, Eng CM, Chintagumpala MM, Berg SL, et al. 2014. Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Med 6: 69.
79. Shahmirzadi L, Chao EC, Palmaer E, Parra MC, Tang S, Gonzalez KD. 2014. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing. Genet Med 16: 395-399.
80. Shamseldin HE, Swaid A, Alkuraya FS. 2013. Lifting the lid on unborn lethal Mendelian phenotypes through exome sequencing. Genet Med 15: 307-309.
81. Shendure J, Ji H. 2008. Next-generation DNA sequencing. Nat Biotechnol 26: 1135-1145.
82. Soothill P, Finning K, Latham T, Wreford-Bush T, Ford J, Daniels G. 2014. Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhDnegative: Implementation in the NHS. BJOG doi: 10.1111/1471-0528.13055.
83. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. 2013.Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 92: 167-176.
84. Tabor HK, Auer PL, Jamal SM, Chong JX, Yu JH, Gordon AS, Graubert TA, O'Donnell CJ, Rich SS, Nickerson DA, et al. 2014. Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: Implications for the return of incidental results. Am J Hum Genet 95: 183-193.
85. Talkowski ME, Ordulu Z, Pillalamarri V, Benson CB, Blumenthal I, Connolly S, Hanscom C,Hussain N, Pereira S, Picker J, et al. 2012. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med 367: 2226-2232.
86. Tiblad E, Taune Wikman A, Ajne G, Blanck A, Jansson Y, Karlsson A, Nordlander E, Hollander BS, Westgren M. 2013. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation-Outcome of a new antenatal screening and prevention program. PLoS ONE 8: e70984.
87. Townsend A, Adam S, Birch PH, Lohn Z, Rousseau F, Friedman JM. 2012. "Iwant to know what's in Pandora's Box": Comparing stakeholder perspectives on incidental findings in clinical whole genomic sequencing. Am J Med Genet A 158A: 2519-2525.
88. Valencia CA, Ankala A, Rhodenizer D, Bhide S, Littlejohn MR, Keong LM, Rutkowski A, Sparks S, Bonnemann C, Hegde M. 2013. Comprehensive mutation analysis for congenital muscular dystrophy: A clinical PCR-based enrichment and next-generation sequencing panel. PLoS ONE 8: e53083.
89. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, GrobmanWA, et al. 2012. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 367: 2175-2184.
90. Wolf SM, Annas GJ, Elias S. 2013. Point-counterpoint. Patient autonomy and incidental findings in clinical genomics. Science 340: 1049-1050.
91. Xue Y, Chen Y, Ayub Q, Huang N, Ball EV,Mort M, Phillips AD, Shaw K, Stenson PD, Cooper DN, et al. 2012. Deleterious- and disease-allele prevalence in healthy individuals: Insights from current predictions, mutation databases, and population-scale resequencing. Am J Hum Genet 91: 1022-1032.
92. Xue Y, Ankala A,Wilcox WR, Hegde MR. 2014. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: Single- gene, gene panel, or exome/genome sequencing. Genet Med doi: 10.1038/gim.2014.122.
93. Yang Y,Muzny DM, Reid JG, Bainbridge MN,Willis A,Ward PA, Braxton A, Beuten J, Xia F, Niu Z, et al. 2013. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 369: 1502-1511.
94. Yang Y, Muzny DM, Xia F, Niu Z, Person R, Ding Y, Ward P, Braxton A, Wang M, Buhay C, et al. 2014. Molecular findings among patients referred for clinical whole-exome sequencing. JAMA doi: 10.1001/ jama.2014.14601.
95. Yeh DD, Imam AM, Truong SH,McLaughlin EL, Klein EN, Avery LL, Velmahos GC. 2013. Incidental findings in trauma patients: Dedicated communicationwith the primary care physician ensures adequate follow-up. World J Surg 37: 2081-2085.